Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Weber

Showing results (171-180 of 194) with videos related to

Pageof 20
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2019
Mapping Prostate Cancer Lesions Before and After Unsuccessful Salvage Lymph Node Dissection Using Repeat PSMA PETAndrea Farolfi, Harun Ilhan, Andrei Gafita, et al.
Nuclear Medicine Communications|October 12, 2023
Correlation of the apparent diffusion coefficient with the standardized uptake value in meningioma of the skull plane using [68]Ga-DOTATOC PET/MRIAleksandar Milosevic, Hanna Styczen, Johannes Haubold, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 13, 2021
Initial Clinical Experience with <sup>90</sup>Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 PatientsJustin Ferdinandus, Pedro Fragoso Costa, Lukas Kessler, et al.
European Urology|June 14, 2020
Efficacy and Safety of <sup>177</sup>Lu-labeled Prostate-specific Membrane Antigen Radionuclide Treatment in Patients with Diffuse Bone Marrow Involvement: A Multicenter Retrospective StudyAndrei Gafita, Wolfgang P Fendler, Wang Hui, et al.
Clinical Nuclear Medicine|December 6, 2018
Hybrid 11C-MET PET/MRI Combined With "Machine Learning" in Glioma Diagnosis According to the Revised Glioma WHO Classification 2016Sied Kebir, Manuel Weber, Lazaros Lazaridis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2022
Novel Framework for Treatment Response Evaluation Using PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer (RECIP 1.0): An International Multicenter StudyAndrei Gafita, Isabel Rauscher, Manuel Weber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 29, 2023
Evaluation of [<sup>68</sup>Ga]-DOTATOC PET/MRI in Patients with Meningioma of the Subcranial and Intraorbital SpaceAleksandar Milosevic, Hanna Styczen, Johannes Grueneisen, et al.
Scientific Reports|December 1, 2022
Prediction of left lobe hypertrophy after right lobe radioembolization of the liver using a clinical data model with external validationJens M Theysohn, Aydin Demircioglu, Malte Kleditzsch, et al.
The Journal of Urology|June 25, 2019
<sup>68</sup>Ga-PSMA-11 Positron Emission Tomography Detects Residual Prostate Cancer after Prostatectomy in a Multicenter Retrospective StudyAndrea Farolfi, Andrei Gafita, Jeremie Calais, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2022
Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer EntitiesWolfgang P Fendler, Kim M Pabst, Lukas Kessler, et al.
Pageof 20

Showing results (171-180 of 194) with videos related to

Sort By:
Pageof 20
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2019
Mapping Prostate Cancer Lesions Before and After Unsuccessful Salvage Lymph Node Dissection Using Repeat PSMA PETAndrea Farolfi, Harun Ilhan, Andrei Gafita, et al.
Nuclear Medicine Communications|October 12, 2023
Correlation of the apparent diffusion coefficient with the standardized uptake value in meningioma of the skull plane using [68]Ga-DOTATOC PET/MRIAleksandar Milosevic, Hanna Styczen, Johannes Haubold, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 13, 2021
Initial Clinical Experience with <sup>90</sup>Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 PatientsJustin Ferdinandus, Pedro Fragoso Costa, Lukas Kessler, et al.
European Urology|June 14, 2020
Efficacy and Safety of <sup>177</sup>Lu-labeled Prostate-specific Membrane Antigen Radionuclide Treatment in Patients with Diffuse Bone Marrow Involvement: A Multicenter Retrospective StudyAndrei Gafita, Wolfgang P Fendler, Wang Hui, et al.
Clinical Nuclear Medicine|December 6, 2018
Hybrid 11C-MET PET/MRI Combined With "Machine Learning" in Glioma Diagnosis According to the Revised Glioma WHO Classification 2016Sied Kebir, Manuel Weber, Lazaros Lazaridis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2022
Novel Framework for Treatment Response Evaluation Using PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer (RECIP 1.0): An International Multicenter StudyAndrei Gafita, Isabel Rauscher, Manuel Weber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 29, 2023
Evaluation of [<sup>68</sup>Ga]-DOTATOC PET/MRI in Patients with Meningioma of the Subcranial and Intraorbital SpaceAleksandar Milosevic, Hanna Styczen, Johannes Grueneisen, et al.
Scientific Reports|December 1, 2022
Prediction of left lobe hypertrophy after right lobe radioembolization of the liver using a clinical data model with external validationJens M Theysohn, Aydin Demircioglu, Malte Kleditzsch, et al.
The Journal of Urology|June 25, 2019
<sup>68</sup>Ga-PSMA-11 Positron Emission Tomography Detects Residual Prostate Cancer after Prostatectomy in a Multicenter Retrospective StudyAndrea Farolfi, Andrei Gafita, Jeremie Calais, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2022
Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer EntitiesWolfgang P Fendler, Kim M Pabst, Lukas Kessler, et al.
Pageof 20